SCHEMBL626467

SCHEMBL626467

N=C1C=CCC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL148004 0.69
SCHEMBL1930705 0.67
Hydrochloric Acid SCHEMBL11629695 0.65
SCHEMBL2326 0.62
SCHEMBL28447922 0.61
SCHEMBL28448242 0.61
SCHEMBL14480727 0.61
SCHEMBL28448217 0.61
SCHEMBL179067 0.61
SCHEMBL11770391 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3645055-A1 REAGENTS FOR OPTICAL MICROSCOPY COMPRISING AN ANTIBODY OR FAB FRAGMENT AND A FLUOROPHORE Alda S.r.L. (IT) 2020-05-06 EP claimed
WO-2019003114-A1 REAGENTS FOR OPTICAL MICROSCOPY COMPRISING AN ANTIBODY OR FAB FRAGMENT AND A FLUOROPHORE ALDA S.R.L. (IT) 2019-01-03 WO claimed
US-12576032-B2 Liquid clonidine extended release composition TRIS PHARMA, INC. (US) 2026-03-17 US disclosed
CN-120076718-A Chewable composition comprising pectin and urolithin 阿马曾提斯公司 2025-05-30 CN disclosed
US-20250134883-A1 NOVEL COMPOSITIONS ARTISAN THERAPEUTICS, INC. 2025-05-01 US disclosed
CN-119451664-A Mutanase and oral care composition comprising same 诺维信公司 2025-02-14 CN disclosed
EP-3906009-B1 MOUSSE-LIKE COSMETIC PREPARATION BEIERSDORF AG (DE) 2024-12-18 EP disclosed
EP-4469027-A2 NOVEL COMPOSITIONS Tulex Pharmaceuticals Inc. (US) 2024-12-04 EP disclosed
EP-4469031-A1 LIQUID RESIN EXTENDED-RELEASE ORAL NALTREXONE FORMULATION FOR TREATING AUTISM-RELATED DISORDERS Aardvark Therapeutics Inc. (US) 2024-12-04 EP disclosed
CN-118984699-A Novel compositions 图莱克斯制药公司 2024-11-19 CN disclosed
US-20240366505-A1 Liquid Resin Extended-Release Oral Naltrexone Formulation for Treating Autism-Related Disorders Aardvark Therapeutics, Inc. (US) 2024-11-07 US disclosed
EP-0783398-A1 RAZOR CARTRIDGES COMPRISING WOUND HEALING COMPOSITIONS WARNER-LAMBERT COMPANY (US) 1997-07-16 EP disclosed
WO-1996039126-A2 RANITIDINE SALTS ON MAGNESIUM TRISILICATE AS AN ADSORBATE WARNER-LAMBERT COMPANY (US) 1996-12-12 WO disclosed
WO-1996019776-A1 PHOTO-ERASABLE DATA PROCESSING FORMS KIMBERLY-CLARK WORLDWIDE, INC. (US) 1996-06-27 WO disclosed
WO-1996010474-A1 RAZOR CARTRIDGES COMPRISING WOUND HEALING COMPOSITIONS WARNER-LAMBERT COMPANY (US) 1996-04-11 WO disclosed
WO-1993008792-A1 LIQUID ORAL COMPOSITIONS COMPRISING DETERPENATED AND FRACTIONATED FLAVOR OILS WARNER-LAMBERT COMPANY (US) 1993-05-13 WO disclosed
EP-0338978-B1 TASTE MASKING OF THYMOL WARNER-LAMBERT COMPANY (US) 1992-08-26 EP disclosed
EP-0314617-B1 CONSISTENT CHEW TEXTURE GUM COMPOSITION WARNER-LAMBERT COMPANY (US) 1992-03-11 EP disclosed
EP-0269571-B1 CHEWING GUM COMPOSITIONS HAVING SEQUENTIAL ACID RELEASE WARNER-LAMBERT COMPANY (US) 1991-07-31 EP disclosed
US-3882186-A Retardation of rubber vulcanization NATURAL RUBBER PRODUCERS & 0 R 1975-05-06 US disclosed